ࡱ> @= XSW\fx4/2s[p xZkl>3׏e'@%؀1ب"ihjm CmZ:iHm-'մMcR%W*D*"Qբ6 iT E=;왻3_tٙ{wν经\깜\It9E Ǎ1;"9Q ˉ} o*s*F @tpa{Em|b%~ýmUpLJ;|LyWvqbZбTV_w"zaAR=eRa_Lӓti;οGOQ?U:ە]~mƺv\JzJ4MqĔ~/MUN꺬c9wd-Z5{;fYٗVO8k5kg} TyuX( M+ ttu^[vsr,oGr9s0O~yft&>p:[\xTǻU^3rAQ2J'2ם2ĥY;Ծ؞W[ iXʿ~keD]*wu9Su m[+6YWO=(R%d J" xk|oi'}eOY-t~M'}śK(/$x%7NxK#|yf7kۈp8:SD;p`+?~h/^>v&F0.?᪺іÆ*෰^׶*=ʰE38k/-ߋ?y(Pվ̤i8%:_n6q/S>-OOڱ?Pe76튻se6[('wܪovM)IIɿ:\ l2'CɛfuJaĐ Oޚ)Co^_{muQ>gk>˯kn._nT6ya]f^.ׯϙ&5ąMSl5k /l28M=xhV xkC[og[6ICiC m 6Yvx~y7ϋUAmp]6 \sXזZ[CV")Aa Oۊ^(o5*=MA^$IGy7&9o- fm⽒&yM?ibBbF7@5 5駗:-,ss-96J,&9]TzT,' |8gЧ昶rڼ{O^;7y>lS7. ^hU&yM$iL`V ^hU&yM biLhUbBbVUB6kUeNcBs.$fXgkGNPGݽvYiiFT_1pvY:]I^6ty&la0+x+ 5i`AW$f.$f/t%ya& l6 ЕĜ Y~ uuA]S[^WQ^2k K+BW6VW7`},vžO^rq\d<7C[޾I^d<&l>^0&1k_x^ڙ{0^hti_S~5JG?Vkӷg{g5xYYUsn0Ǻo+_` cx1H^$o1L`V:7sMkYbBbV:7sMt07sĜ 5 =ve F}p8Y_47n 5tַ}o:xodi ДMGsހ [J5^hJ&yrPS$f.$f/4%yaa׻$\HJ5W17T;>ZOcx w4^hJ&yS7`RMI^; MI\HJ5^hJ&yMm0)9*DYAM&9*>Vkާ]}In5D$ dY+zd\!@ACD FvE!HIK /X$"$XSW\fx4&  0AA @845 g4KdKdD\ 0ppp@ <4BdBd@k 0tt2ʚ;ʚ;<4dddd@l 0@g4 d d] 0vpk p0___PPT10 ___PPT9/ 0&  134579;&>(A&? %O =#\ &Preparation for Life After Fellowship  '&(CRobert F. Todd, III, MD, PhD University of Michigan Medical School (DB$( 8 It is the Best of Times&   ( Never before in the history of medical science have the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of the human genome and the genomes of relevant animal models (C elegans, Drosophila, mouse& ) Identification of disease-specific/-related genes. Improved understanding of genetic basis of cancer predisposition/molecular pathogenesis. Identification of molecular targets for novel drug development ( targeted therapy ). 66:" " \" " <$ 69  \ @ & the best of times (continued) 8!$ $$ NIH funding doubled in past decade. New federal opportunities for extramural support of clinical research. Other federal and non-federal sources of extramural support of cancer research abound. Medicare (and certain other insurance vendors) to pay for cancer clinical trials. BnP$$ @ & the best of times (continued) .!$ $vEmergence of a robust biotechnology industry and the investment of the pharmaceutical industry in cancer drug development create opportunities for progress. New employment opportunities in the biotech and pharmaceutical industry. The market for both private practice and academic jobs in hematology/oncology is excellent (field of medical oncology is not oversaturated). wwe +(Private Practice versus Academic Career))$/Personal preference (e.g., an influential role model) Dominant interest in patient care Interest in conducting research/medical education. Generally the purview of the academic health center. Limited opportunities for medical teaching and clinical research may exist in private practice. CompensationX"   QEASCO Time/Activity Analysis Comparison of work activities (% of effort) by main duty: patient care, laboratory research, and clinical research.$t$  /Major Areas of Academic Research Opportunities00$Basic (laboratory-oriented) research: fundamental or applied (translational) laboratory investigation. Diverse areas of emphasis include: Cancer Genetics (e.g., oncogenes, tumor suppressor genes, etc). Cancer cell biology (e.g., cell cycle regulation, signal transduction, regulation of cell death/apoptosis). Tumor immunology (cellular and humoral immunity to cancer; vaccines, etc). Vascular biology, thrombosis, and hemostasis. Cancer etiology (virology; chemical, physical, and hormonal factors; etc). Cancer pharmacology.B" $i ;Major Areas of Academic Research Opportunities (continued)"<0$ Clinical research: academic career that combines clinical care with clinical research General trend toward sub-subspecialization (e.g., lung cancer, breast cancer, thrombosis and hemostasis) (clinical investigator becomes expert in one type of cancer). Focus on experimental therapeutics of cancer using pharmacologic and biologic forms of therapy. Involves collaborations with translational scientists in academic centers or industry. Phase I, II, III clinical trials. Health services/outcomes research. \W" Fp| ;Major Areas of Academic Research Opportunities (continued).<0$  XHybrid (laboratory/clinical investigation) Professionally gratifying to translate progress in the laboratory to the clinic (bench to bedside). Challenging for any single individual to achieve sustained progress both in the laboratory and in the clinic. Alternative is a highly interactive team of laboratory and patient-oriented collaborators.L,-" &,4Private Practice versus Academic Career (continued).5)$ $Compensation Private practice generally offers higher levels of compensation as compared to academic careers. For basic or laboratory investigators, industry may provide greater compensation than in academia. Within academic health centers, market forces influence compensation: clinical investigators generally have higher salaries than laboratory scientists; bone marrow/stem cell transplanters are highly valued. P "  UG:Compensation (Salary) in Academic Health Centers (by rank);:$VFGCompensation (Salary) in Oncology-Related Private Practice (MGMA, 2003)HG"7.Finding a Job After Fellowship$Identifying employment opportunities. The academic employment interview. Criteria for success in getting the position. Types of academic appointments. The academic offer letter. (8/1Methods of Identifying Employment Opportunities 22$Journal advertisements (e.g., J Clin Oncol, Blood, NEJM, JNCI, etc). ASCO/ASH websites and national meetings. Personal contacts. Mentor contacts.  T, i90EThe Academic Employment Interview: How to Prepare and What to ExpectFF$wThe academic employment interview provides an opportunity for individual meetings with the unit director as well as multiple prospective faculty colleagues. In preparation for the interview, request advance information to include the roster of interviewers, the unit annual report or other summary information describing the professional/clinical activities of the unit, etc.xw:1QThe Academic Employment Interview: How to Prepare and What to Expect (continued)"RF$ #Develop a polished 50 minute seminar in the area of research/clinical interest. Pay special attention to the quality of the presentation and visual aids. Target the presentation to an audience with a general knowledge of the topic to be presented. Provide sufficient background information.BP " P;2=General Criteria for Success in Getting the Academic Position>>$Evidence of broad clinical training in the desired discipline with, if necessary, focused expertise in a targeted clinical arena. Strong foundation for an independent scientific career as evidenced by publications and by letters of reference. Success in competing for initial grant support that is preferably  mobile to the new institution (e.g., multi-year grants that are transferrable). Positive professional image on interview; excellent interpersonal skills.<3Types of Academic Appointments Tenure track The concept of  tenure may have different definitions at different institutions. At most medical schools tenure does not mean lifetime job security at full salary. At some medical schools tenure is restricted to laboratory-oriented faculty.T " xx=4*Types of Academic Appointments (continued).+$ $8Clinical/educator track At many schools this track is targeted to the appointment of faculty whose major responsibility is clinical care and medical education. There may or may not be an expectation to pursue clinical investigation. Clinical track faculty generally have renewable academic appointments without a long term (tenure) employment obligation. At some institutions, clinical track faculty may be full time employees of the academic health system or, alternatively, the full time employees of affiliated hospitals, who serve as volunteer teaching faculty. D !" >5The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level)2=$C$Independent laboratory space: generally 500-1,000 sq. ft. depending upon experience of the individual and resources available. Independent office space. Laboratory start-up funding. Amount dependent upon resources required to pursue the individual s laboratory research ($200-500,000). Start-up funding is used to purchase equipment, supplies, recharge rates for shared core facilities, hire technical support: sufficient to run a small laboratory operation for 2-3 years pending success in receipt of extramural support. D V" T?6The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)6=$C PAvailability of  protected time : generally 75-80% exclusive of clinical and educational responsibilities. Protected time guaranteed for 2-3 years pending acquisition of independent extramural salary support. Competitive salary and benefits. Letter should indicate criteria for merit raises/bonuses and other factors that may influence the salary. Terms of the appointment with criteria for achieving tenure/reappointment. l f" ! j" K lf!jJ@7The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)6=$C RAncillary support: availability of secretarial/ administrative (e.g., grant management) support. Availability of senior mentor. A junior faculty member will continue to benefit from the availability of one or more senior faculty mentors to ensure the individual s successful career development. >" A8jThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator 2k?$* $The availability of patients (with relevant diseases) to serve as potential human volunteers in clinical research studies. Clinical effort should be targeted to the research area (versus nonacademic clinical service). 2B9uThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)Vv?$*   {Availability of relevant laboratory/clinical collaborators. Availability of ancillary services critical to clinical research (e.g., radiology, clinical laboratory, etc.). Availability of support personnel. Secretarial/administrative support. Physician extender support (which may be critical to provide technical support for clinical research studies). Data management personnel.F " C:uThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)Fv?$*  Availability of senior mentor (just as critical for the career development of a clinical investigator as for a basic laboratory investigator). Clearly stated protected time to pursue academic efforts and criteria for maintaining protected time (e.g., expectations for extramural support, etc.). Clearly stated terms/type of appointment with criteria for tenure (if applicable) and reappointment. D;uThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)Fv?$*  Competitive compensation/benefit package Criteria for achieving merit salary increases/ bonuses. Productivity criteria affecting level of salary. Availability of core facilities . e.g., clinical research center. Biostatistical support. Availability of assay laboratories.z) i" " \" )i"[G<PRIVATE PRACTICE$tFellowship preparation. Types of practices. The private practice offer letter. Opportunities for career advancement.(usH=-Preparation for a Career in Private Practice.. Scope/breadth of training experience. Need to be skilled  generalist . Training in medical oncology is essential given the volume of patients with malignant diseases relative to those with non-malignant hematopoietic disorders. Training in benign hematology (e.g., thrombosis/ hemostasis) provides greatest flexibility for employment opportunities. h& 7" &6I>9Preparation for a Career in Private Practice (continued).:.  Clinical research experience is valuable training for private practice. Opportunities to conduct clinical research may exist in certain private practice settings. Community Clinical Oncology Programs (CCOP) Contract Research Organizations (CROs)vH" [ S" GZRWH9Preparation for a Career in Private Practice (continued)":. LClinical research experience is valuable (cont) Helpful in critical evaluation of new therapies The private practitioner must be able to critically evaluate the experimental basis for new/emerging therapies since the difference between established vs  cutting edge therapies is often blurred!d0000J?'Types of Private Practice Opportunities((  Solo practice (!) Subspecialty Group: group of practitioners who practice medical oncology +/- hematology. Single specialty networks (e.g., U.S. Oncology). Multi-specialty group (including HMO): one or more hematology/oncology practitioners in a group practice with other subspecialists.Zl 1"  l1K@3Types of Private Practice Opportunities (continued).4(  nIndependent; hospital-based; university-affiliated Independent responsible for both revenues and expenses of practice. Hospital-based; university-affiliated; receives salary from hospital or academic health center which may cover practice overhead. Opportunities to conduct teaching; clinical research? Academic appointment (generally volunteer teaching faculty)? L3 ;" 3;LABPrivate Practice Offer Letter: What to Expect and How to EvaluateCC$1Compensation/benefits (generally start as probationary employee). Criteria for raises/bonuses/profit-sharing. Anticipated workload. Ambulatory clinic hours. Hospital rounding responsibilities. On-call time. Level of ancillary support. Nursing personnel to deliver chemotherapy. Physician extender support.z K"  G" KFMBBPrivate Practice Offer Letter: What to Expect and How to EvaluateCC$wTime for professional development (e.g., attendance at professional meetings). Requirement for hospital appointment/privileges. Terms for achieving partnership in practice. When (1-3 years)? How much to buy a percentage of practice (repaying practice for its upfront investment in salary, benefits, and overhead)? Terms of payment (pre-tax salary differential, loan, etc.). T " NCSUMMARY J It is the Best of Times&  to pursue careers in Oncology and Hematology practice and research. Never before in the history of medical science have the opportunities to advance these fields been greater. Advice: Decide basic career goals and then PREPARE for future success. 8&Q/YP"  0` f3"V+Nf` 3f3f3f` /.fRP̙` f"ffH` f3f|` MMM>?" dd@,|?" dd@   " @ ` n?" dd@   @@``@n?" dd@  @@``PR    @ ` ` p>> J(    H,$D 0   BCPE(F"2@ 8ApP XP@  `@   0e0e     ?BCE<F& 2@ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||FP P  - ffFF@    `F   BCETF.@' EuOE[: :Pf@      `   0e0e     ?BCE`F2 @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||hD[Drmq>uJ^_! BE@       `  S BhC! E<F&@ ! v" bN'\h4ht-2.#; [! ! @    `   0e0e     ?BCETF. @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||$ )  _s0|d T A% :$@      `y   0e0e     ?BdCHEHF* @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||A @<PdT H"k=_ E;W@     `Y  s * P  T Click to edit Master title style! !   c $|   TClick to edit Master text styles Second level Third level Fourth level Fifth level!    U  c $ ``  Z* 2  c $ `   \*(2  c $  `   \*(2r  Z2޽h))?? ;M;;;;f___PPT10+ D' = @B DW' = @BA?%,( < +O%,( < +D' =%(%(D' =%(D' =4@BBBB%(D' =1:Bvisible*o3>+#.<*%(D' =+4 8?dCB0-#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*+ Ribbons  0 @ (    H,$D 0   BCPE(F"2@ 8ApP XP@  `@   0e0e     ?BCE<F& 2@ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||FP P  - ffFF@    `F   BCETF.@' EuOE[: :Pf@      `   0e0e     ?BCE`F2 @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||hD[Drmq>uJ^_! BE@       `  S BhC! E<F&@ ! v" bN'\h4ht-2.#; [! ! @    `   0e0e     ?BCETF. @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p@A)BCD|E?||$ )  _s0|d T A% :$@      `y   0e0e     ?BdCHEHF* @ 5% 8c8c     ?1 d0u0@Ty2 NP'p<'p @A)BCD|E?||A @<PdT H"k=_ E;W@     `Y  s *2 p  T Click to edit Master title style! !  c $02  `   2 W#Click to edit Master subtitle style$ $  c $2 `` 2 ^* 2  c $2 `  2 `*(2  c $2 `  2 `*(2r  Z2޽h))? ? ;M;;;;f___PPT10+ D' = @B DW' = @BA?%,( < +O%,( < +D' =%(%(D' =%(D' =4@BBBB%(D' =1:Bvisible*o3>+#.<*%(D' =+4 8?dCB0-#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*+ 0 *(    0 t$   X*   0  3$  Z* d  c $ ?OG    0\  |   RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S  6L t   X*   6  3  Z* H  0j ? 3380___PPT10.g5Pp 0(     N9k9k t$   v* J%%JJoo  N\9k9k  4$  x* J%%JJoo  Td9k9k t   v* J%%JJoo  TD9k9k  4  x* J%%JJooH  0j ? ̙3380___PPT10.a5  0 `*( |ė8 x  c $2 P  2 r  S ԛ2  2 H  0޽h ? ff̙33 0 ` $(   r  S 2  @P 2 r  S 2  2 H  0޽h ? ̙33  0 p$$(  $r $ S     r $ S T p  H $ 0޽h ? ff̙33  0 ($(  (r ( S )    r ( S *  `  H ( 0޽h ? ff̙33  0 *(  x  c $ 9    r  S 9   H  0޽h ? ff̙33  0 h,(  hr h S H    z h 0A  /??"`` /H h 0޽h ? ff̙33  0 4$(  4r 4 S \O    r 4 S t2 ``   H 4 0޽h ? ff̙33  0 <$( < <r < S E `   r < S 1  @ 1 H < 0޽h ? ff̙33  0 P@*(  @x @ c $,l P   r @ S p 0  H @ 0޽h ? ff̙33  0 H$(  Hr H S Lk `   r H S (1    H H 0޽h ? ff̙33  0 +pA( w px p c $ P    p 0pP`,$ 0 : 2   0  p #"&yih 0   1p < ?,J 0  U261,914 @` 2p < ?( J ,  U195,320 @` 3p <  ?J (  U182,097 @` 4p < ? J   y90th Percentile8  @` 5p <  ?"`, 0J  U214,517 @` 6p <  ?"`( ,J  U170,489 @` 7p <   ?"` ( J  U157,301 @` 8p < ?  J  y75th Percentile8  @` 9p < ?,b0  U187,872 @` :p B) ?( b,  U154,259 @` ;p <4" ?b(  U127,308 @` p <L ?( ,b U137,423 @` ?p <U ?( b U115,313 @` @p <DP ? b y25th Percentile8  @` Ap <d[ ?,0 h Professor,   @` Bp <dt ?( , qAssociate Professor,   @` Cp <h~ ?(  qAssistant Professor,   @` Dp <y ?  X  @`fB Ep 61 ? fB Jp 61 ?   fB Kp 61 ?  fB Xp 61 ?00fB p 61 ?( fB p 61 ?  bfB p 61 ?( ,fB p 61 ?,0fB p 61 ?00bfB p 61 ? b  fB p 61 ?0b0 fB p 61 ?  J fB p 61 ?0 0J fB p 61 ? J  fB p 61 ?0J 0 fB p 61 ? ( fB p 61 ?( , fB p 61 ?, 0   _p 6p From the Medical Group Management Association Physician Compensation and Production Survey: 2004 Report Based on 2003 Data (5)022H p 0޽h ? 33̙33  0 UM *ul( Ow@ lx l c $ P   % l 0,p4 From the Medical Group Management Association Physician Compensation and Production Survey: 2004 Report Based on 2003 Data (5)* 2t E  ul #"&@E  l B0? E  U672,470 @` l Bܵ? E  U262,884 @` l B?P  E  U882,118 @` l B$? PE  y90th Percentile8  @` l BP ?"`   U524,500 @` l B ?"`   U189,798 @` l B ?"`P   U530,021 @` l B(? P  y75th Percentile8  @` l BT?P  U405,209 @` l B? P  U167,817 @` l B ?PP  U315,969 @` l B?PP  RMedian @`  l B?P U307,928 @`  l B? P U144,927 @`  l Bd0?P P U227,273 @`  l B:?PP y25th Percentile8  @`  l BD? qRadiation Oncology,   @` l BN?  }Pediatric Hematology/Oncology,   @` l B@Y?P  wAdult Hematology/Oncology, @` l B`b?P X  @`fB l 6o ?PfB l 6o ?E PE fB  l 6o ?fB :l 6o ?  fB $l 6o ?fB ;l 6o ? E fB Ul 6o ?P fB Vl 6o ?PfB Wl 6o ? fB Yl 6o ?fB \l 6o ?PfB ^l 6o ?P fB dl 6o ?P fB fl 6o ? fB il 6o ? E fB ll 6o ?PE  E fB nl 6o ? E E fB pl 6o ?E E H l 0޽h ? ;M;;;;f  0 $( Ow@ r  S 5 P   r  S pO pp  H  0޽h ? ff̙33  0  $( w  r   S     r   S  P   H   0޽h ? ff̙33  0 $( w r  S w    r  S x p  H  0޽h ? ff̙33  0  $( w r  S h     r  S @   H  0޽h ? ff̙33  0 0$( f! r  S     r  S  Pp  H  0޽h ? ff̙33  0 @$( Ow@ r  S      r  S H P0p  H  0޽h ? ff̙33  0 P $( w  r   S     r   S x `   H   0޽h ? ff̙33  0 `$$( w $r $ S     r $ S    H $ 0޽h ? ff̙33  0 p($(  (r ( S (    r ( S     H ( 0޽h ? ff̙33  0 ,$(  ,r , S  P    r , S    H , 0޽h ? ff̙33  0 0$(  0r 0 S     r 0 S   @  H 0 0޽h ? ff̙33  0 4$(  4r 4 S 0 P    r 4 S  P0  H 4 0޽h ? ff̙33  0 8$(  8r 8 S @ Pp   r 8 S   P   H 8 0޽h ? ff̙33  0 <$( w <r < S \     r < S *1 p  H < 0޽h ? ff̙33  0 @$(  @r @ S 6 P   r @ S 7 @``  H @ 0޽h ? ff̙33  0 D$( , !TM Dr D S G    r D S XH    H D 0޽h ? ff̙33  0 H$( Ow@ Hr H S O    r H S lP   H H 0޽h ? ff̙33  0 `x( @  ` xl x C 0[    l x C ^   H x 0޽h ? ;M;;;;f  0 L$( w Lr L S m `   r L S n   H L 0޽h ? ff̙33  0 P$( , !! Pr P S | P   r P S l}   H P 0޽h ? ff̙33  0  T$( w Tr T S     r T S  ` 0   H T 0޽h ? ff̙33  0 0X$(  Xr X S     r X S 4   H X 0޽h ? ff̙33  0 @\2( H0 \r \ S c2 P  2  \ S 2  2 H \ 0޽h ? ff̙33 G 0 (  X  C OG     S  |     H  0j ? 3380___PPT10.g5`חx= tTյ5?$"I%1@Ā ȧjOC2If2!ZR+-,>B6ojvUZ[bZmPX`sgνw& {֞s}{Ͼ{?٘7`=@.LQo_pt`0 #s;=*KóetywJM<mf)C0%2xAUjJh5i![Թry\(0tR*zO5NU8 cjc Ec:F{=b_ 7"ބq)2ě#@\ 񳈷 ފx~@qoƐ 1$tE;#k\*@4Ypyq|]>8O;`g/tzUyJhJ*h96/c(/Hw%%4 ;8nc J$6RD/3\+j,”(4~D,R+kL #[sxӍixR4*Gp/GPj_(P8_79WMJ RmY>ދZrb0pTXӅN#Ceܰ`(7x3AS0=8^T3Y8~Jep+uKkSKa61ՇbUUtu0՝B8z6:l+,xb+5{P=gx@a+@`{PؒxK\˩t U+[W@8(Ufggc)3#Cc''{c]bU܁B:ސ {hTP6ݡ4 p%*,FA-n FvB:*8%J6 u/f`wӮ$>UF9 ֽǛX#E-"R(Bǎ&Q[Pũ3O)$J:_ KwGo@_))&]ZGGinڕ5ECCэG` Z El?~2 )Ήp YJ;$*gc)EMLĝzSZ(Ρ>˅ܜw1 vD7>s}&:x(-c).oAcW݂dAJ4/LJ}yR#۸۔D{}ͽL[;Ui5y)M`cWSY:w Vz{unJnhs5ZnPGc1 ~ ]gNiWf׍0JǕX)-/˺qi Fһglj6d[-Z![ZV]ڛ{f^\!*1f^cd^5.kw2Ei/1njhl C.{UC=y9IYme+RfgF ̜Ȝ2iX3ceNtCtƉ hv^s;pwHQG0<'z:L"{KӬeJ%R!Li2 q2k2oO.]הƦPG^11]fYwFLp22o%.(-Yw@ͺn|4zVUIi2Y5+Ƌ ndOY/CwHfSNdz2# s4u-CdN5g8v6ތv̚4x4ktת q2kt#kF85W8QS*v5k"7k2^Fi2 q2k2)y9)[$<{2tF_Ε_#(MF,D4J44(M?+P/F8)ZTB)(]>|zl֬]ۑͰjoj _2%xLMoGL¸|6`;ւ+ğ ٰ kf|ucr4lAB9,,(|E$yk0XI%?)$^S=ڣALXS7~r-Y>YОe+θ=KNS\&UV(wNLW:Թ*], LrŸUj\\DA̭vո\b"U2; `n\Yn"M +Vv`8q.⭈!v!v# >qⓈO!ez5wO"K:wI$.V6{R0⭝ ڱKHs ,E\JvN6C&bPnཤIsS:8N}mHR'a*VF+jo;~b3a5ּؐm,PYV`[vEKU񈋥mxqCҘ?Ə_ƒÈGJ['N0x}bEژs?uSC;nB +PQvKTU bܐ뤃rιn@/cFZ-s) / ߲'`ą2 vLJvpxs2iQ%=cQ?%l5 dk[q#N^O~&s'v&(t,s]i `z㖇O}i[aOu{{8~ p  |]c_IWڿg + NWC{{|ŝg;󬽼m`8mj fS;DNjA$tbEaB C!8{MI)IrevyX ZpXU , , , 2ӛZl)I`4 g?%cs/n6?4!|56GGk!;GD> ߳'5)< e/pAUzƪ`Ww(1i jj 6vp Eϊl?Q8!Wڣ͟O'2mH|_8SVS[w,[TdDP5g!B@X P k JWʰf)@ʶ , , ,S /> .| COr_R>jI}+|6ڮVΐ|#?q ydJo*3D[k,w\ _2Q5/wFs5 231P.ʐrņzmL fS*/ޅE{|&9:gNLH5ϧ>?$?0+c=s(u8<R9ڛg}X`X`X`X0\a7eoz1=W׈߫vw"M~wIs$:!xh=UVZR^=Iޭ,~\T{|X`X`X`v='9mw\ulۦs[iAB9,/ =C6,pT~_/ʥR0_Ak3`{ާ/ov|WmƐMJ@xD J/pM <,)ɛ{c,h&/:kc#gW^_pj80ۏ١G-#vW\&)#ʩXv,`@)yy"V E6.nw"B|)? *k D|CWF|/!oߡ?iI\"PXvGgHosx:&Q.QX9)q@#l`)rUvun8E^~|g:ؙ-Ag5 ,BLLNDf&Q:OoZs&oyisgC1,2 MekNgNoN| gm=DoOXqܩTRdy%3G .[PEY%b?+έZp;ʽ;u.]0߃D}5]C܆]km"}[V=}P &$@pphs"@|H?,˄O ok!>簿°m/~ė\ҿ^?kÈǿ97.BOD| .2_B? Lg? |WB<6/D}{t>4盇Չ\;<.RV-5cSkNV>LiшNjs;踿6-$.?ѱ޲Աw[ķ43G8.ے=Log#ڰ<$c'.NYVլx;c  y<):LU jx*+jmNy];Z$ﲫw DZ3s5B,%8Н>+pj'bٳf𴥱pŴ:渥=Ӆγ딳ٲ'L#կ݅;/!JQl߀jDRTuҊ`$@g~>pO^ic J3z/q::_ KwGf Ŀw򯮌T"@_]!OKc[G` 4 Elj*QO<`<)Jcm,<V"qƿޢjoou} k=o;/^ ڻ08%`Lݩ̲Ku#e *JTo2n#Wb}j;ǑL׺2KGkzVJґZ^3%ztG/dז,Q:; $~Oj2csUM|$IglяdVlW7B >"&讃3jٮs!x~ӕVF#J/|XOotȧ^j7iK6 R;hћHt?r?n'O6ӑ,DPm|d(8!CYlPV:=hD/KTDy襔hT޲(Ooi޻k5Pma5jxjQUNEJ`+Iqѓ 3ۇ4WҤ T AzIf&?̯~׭IՒ%,ҧs]*6w3I*[aaZr  0r^ J0049ht`L 8 $Gp\!(%')*,P 0<UPH#.LY1Oh+'0ZTTdZT |ZpZ UWZZZ@^#@`SKlj@O3@2)SxGSg  )'    """)))UUUMMMBBB999|PP3f333f3333f3ffffff3f̙3ff333f333333333f33333333f33f3ff3f3f3f3333f33̙33333f333333f3333f3ffffff3f33ff3f3f3f3fff3ffffffffff3ffff̙fff3fffff3fff333f3f3ff3ff33f̙̙3̙ff̙̙̙3f̙3f333f3333f3ffffff3f̙3f3f3f333f3333f3ffffff3f̙3f3ffffffffff!___wwwff4'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___wwwDžDžǡφφφφφφǧǧǧǡǡǡϡǧǧǧǧǧφφφφǡǡǧφφφφφφφφφǧǧǧǡǧǧǧφφφφφφǡǡǡφφφφφφǧǧǡǡǧǧǧǧφφφφǡǡǧǧφφφφφφφφφφǧǧǧǡǡφǧǧǧφφφφφφDžDžǡφφφφφǧǧǡǡǡǧǧǧǧǧφφφφǡǡǧφφφφφφφφǧǧǡǧǧǧφφφφφφǡǡφφφφǧǡǡǧǧǧφφφφǡǡǡǧǧφφφφφφφǧǧǡǡǧǧφφφφφφDžDžǡDžφφφφǧǡǡǡǧǧǧǧǧφφφϡǡǡǧφφφφǧǧǡǧǧφφφφǡǡǡφφφǧǡǡǧǧφϡǡǡǡǧǧφφφφφφφǧǡǡǧǧφφφDžDžǡǡφφǡǡǡǧǧǧǧǧφǡǡǧφφφφφǡǧǧϡǡǡφφǧǡǡǧǧǧǧφǧǡǡǡǧǧϡφφφφǧφǡǡǧǧǧφφDžDžǡφφǧǡǡǡǧǧǧǧǧφφφǡǧφφφφφǧϡǡǧǧφφφφφǡdžφφφφǧǧϡǡǡǧǧǧφφφϡǧǧǧφφφφφφφφǧφϡǡǡǧǧǧφφφφφDžǡφφφφǧφϡǡǧǧǧǧǧφφǡǧφφφφφφǧǧφϧǧǧǧφφϡǡǡǡφǧǧǧǧǧǡǡǡφφφφφǧǧǧǧφφφDžǡǡφφφφǧφφ88ǧ888φφφφφφφφφφϧ8φφφφφφϡφ888φφφφφφφ88888888888888888888888888888888888888888888888888888888888888888φφφ888888888888888φ888φ88888888ǡ888888888888888888888888888888888φφ888888888888888888888888888888888888888888888888888888888888φφφφφ8φ888888888888888888888888888ϡ88888888888888888888φ8888888888888888888888888φφ8888888888888888888φφφ88888888ǧǧ888888888ǡ8ǡ8ǡ888888ǧǧǧ88ǧ888888φφφǧǡǡǧφφφφφφǧǧǡǧǧǧφφφφφǡǡφφφφǧǧǧǡǡǧǧǧǧφφφϡǧǡǡǡǧǧφφφφφǧǡ88ǧǧǧǧ8φφφφφ8888888888888888888888888888888888888ǡ888888888888888888888888φ888888888888888888ǡ88888888ǧ8ǧ88888φφ8888888888888888888888888888888888888φφφ88888888888888888φ8φ8888ǡ8888888888888888φφ888888888888888ǡ88888888888φφφ88888ǧǧ8888888888φφ8φ8φ888888888888888888888888888888ǧǧǡǡφφφφφφφφǧǧǧφφφφφφφǧǧǧφφφφφǧǧǧǧǡǡdžφφφφφǧdžφφφφφφǧǧǧǧǡφφφφφφǡφφφφǧǧǧǧǡǡǧφφφφǧǧǡǧǧφφφφφφφφǧǧǧǧφφǡǡφφφϧǧφφφφφφφφφφǧǧǧǧǧǧǧǧǧφφφφǧǡǧφφφφφφǧǧǧǧφφφφφφǧǧǧφφφφφφǡǡǡφφφφǧǧǧǧφφφϡǧǧǧǧφφφφǧǧǡǡǡǧǧφφφφφφφφǧǧǧǧǡǡǧǧǧǧφφφφφφDžDžǡǡφφφφǧǧǧǧǡǡǡ8888ǧǧǧǧǧφφφφǧǡǡ88ǧφφφφφφǧǧǧ888888888888888888888888888888ǧǧǧφφφφφφ888888888888888888888888φφφφǧǧǧ8888888888888888888888888888ǧǧǧφφφφǧǧ888888888888888888888888888ǧǧφφφφφφφφǧǧǧ888888888888888888888888888ǧǧǧφφφφφφ888888888Džǡǡφφφφǧǧǧ88888888888ǡǡ88888ǧǧǧǧǧφφφφǧǡǡǧφφφφφφ8888ǧǧǧǧǡǧǧǧφφφφφφ88ǡǡǡφφφφ88888888888888888888888888888888888888888888888888888888888ǧ8888888888888888888φφϡǡǡǧ8888888888888888888888888888888888ǡ88ǡ8888888ǧ8ǧ8888888888ϡǡǧǧǧǧ8888888888888888φ888888888888888ǡ8888888888888888888888888888φφφφDžǡǡ888888888888888888888888888888888888Dž88888888888888888888ǡǧǧǧǧ88888888888888888888888888888888888888888888888888888ǧ88ǧǧ88888888888888888φǡǡǡǧ888ǧ8dž88ǡ8888ǧ88888ǡǡǭ8888ǧǧǧǧ88888φφ88888888ǧǧ8888ǧǡǡǡǡǡφφǧǧǧǧǡǡφǧǧǧǡǧǧǡǡǡǧǧǡφφφφφφφφǧǧǧǧǡǡǧǧφǧǧǧǧDžDžǡǡDžφφφφǧǧǧǧǡǡǡǧǧǧǧǧǧǧǧǧφφφǧǡǡǧφφφφφφǧǧǧǧǡǧǧǧφφφφφφǡǡǡφφφφǧǧǧǧǡǡǧǧǧǧφφφφǧǧǡǡǡǧǧφφφφφφφφǧǧǧǧǡǡǧǧǧǧφφφφφφAfter FellowshipIrelan PatrickIrelan PatrickT&lt;p&gt;Preparation for Life After Fellowship Robert F. Todd, III, MD, PhD University of MichigaRoot EntrydO)!W/PicturesCurrent UserSummaryInformation([n Medical School  It is the Best of Times&  Never before in the history of medical science have the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of the human genome and the &lt;/p&gt;T&lt;p&gt;Preparation for Life After Fellowship Robert F. Todd, III, MD, PhD University of Michigan Medical School  It is the Best of Times&  Never before in the history of medical science have the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of the human genome and the &lt;/p&gt;EktTaxCategoryEktDisabledTaxCategory]# 'Times New Roman WingdingsRibbonsMicrosoft Word Document(Preparation for Life After Fellowship It is the Best of Times ՜.+,D՜.+,<      H   On-screen Show]# 'Times New Roman WingdingsRibbonsMicrosoft Word Document(Preparation for Life After Fellowship It is the Best of Times Root EntrydO)+W/PicturesCurrent UserSummaryInformation([_M0lstarklstark  !"#$%&'()*+,-./0123456789:;<=>?՜.+,՜.+,<      H   On-screen Show]# 'Times New Roman WingdingsRibbonsMicrosoft Word Document(Preparation for Life After Fellowship It is the Best of Times $the best of times (continued) $the best of times (continued) ,Private Practice versus Academic CareerASCO Time/Activity Analysis Comparison of work activities (% of effort) by main duty: patient care, laboratory research, and clinical research0Major Areas of Academic Research Opportunities<Major Areas of Academic Research Opportunities (continued)<Major Areas of Academic Research Opportunities (continued)8Private Practice versus Academic Career (continued)<Compensation (Salary) in Academic Health Centers (by rank)HCompensation (Salary) in Oncology-Related Private Practice (MGMA, 2003) Finding a Job After Fellowship4Methods of Identifying Employment Opportunities HThe Academic Employment Interview: How to Prepare and What to ExpectTThe Academic Employment Interview: How to Prepare and What to Expect (continued)@General Criteria for Success in Getting the Academic Position Types of Academic Appointments,$the best of times (continued) $the best of times (continued) ,Private Practice versus Academic CareerASCO Time/Activity Analysis Comparison of work activities (% of effort) by main duty: patient care, laboratory research, and clinical research0Major Areas of Academic Research Opportunities<Major Areas of Academic Research Opportunities (continued)<Major Areas of Academic Research Opportunities (continued)8Private Practice versus Academic Career (continued)<Compensation (Salary) in Academic Health Centers (by rank)HCompensation (Salary) in Oncology-Related Private Practice (MGMA, 2003) Finding a Job After Fellowship4Methods of Identifying Employment Opportunities HThe Academic Employment Interview: How to Prepare and What to ExpectTThe Academic Employment Interview: How to Prepare and What to Expect (continued)@General Criteria for Success in Getting the Academic Position Types of Academic Appointments,Types of Academic Appointments (continued)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)lThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)PRIVATE PRACTICE0Preparation for a Career in Private Practice<Preparation for a Career in Private Practice (continued)<Preparation for a Career in Private Practice (continued)(Types of Private Practice Opportunities4Types of Private Practice Opportunities (continued)DPrivate Practice Offer Letter: What to Expect and How to EvaluateDPrivate Practice Offer Letter: What to Expect and How to EvaluateSUMMARY  Fonts UsedDesign TemplateEmbedded OLE ServersSlide Titles#T\$ h p |  <0EktContentID64EktContentLanguageEktFolderId64 EktQuickLinkEktContentTypeEktFolderName EktCmsPath EktExpiryType EktDateCreated EktDateModified EktTaxCategory EktCmsSizeEktSearchableEktEDescriptionEktExclude_From_CalendarEktHomepage_news EktASH_EventEktRelated_Item_HeadlineTypes of Academic Appointments (continued)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)The Academic Offer Letter What to Expect and How to Evaluate Laboratory-oriented physician scientist (assistant professor level) (continued)lThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)xThe Academic Offer Letter: What to Expect and How to Evaluate The patient-oriented clinical investigator (continued)PRIVATE PRACTICE0Preparation for a Career in Private Practice<Preparation for a Career in Private Practice (continued)<Preparation for a Career in Private Practice (continued)(Types of Private Practice Opportunities4Types of Private Practice Opportunities (continued)DPrivate Practice Offer Letter: What to Expect and How to EvaluateDPrivate Practice Offer Letter: What to Expect and How to EvaluateSUMMARY  Fonts UsedDesign TemplateEmbedded OLE Servers EktInPermEktDescription EktKeywordsEktShort_TitleEktRelated_eventsEktContentSubTypeEktDisabledTaxCategory   DownloadAsset.aspx?id=2715e@=] @_>]  GRelated ItemsT&lt;p&gt;Preparation for Life After Fellowship Robert F. Todd, III, MD, PhD University of Michigan Medical School  It is the Best of Times&  Never before in the history of medical science have the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of the human genome and the &lt;/p&gt;ity of Michigan Medical School  It is the Best of Times&  Never before in the history of medical scienceSlide Titles#T\$ h p |  <0EktContentID64EktContentLanguageEktFolderId64 EktQuickLinkEktContentTypeEktFolderName EktCmsPath EktExpiryType EktDateCreated EktDateModified EktTaxCategory EktCmsSizeEktSearchableEktEDescriptionEktExclude_From_CalendarEktHomepage_news EktASH_EventEktRelated_Item_Headline EktInPermEktDescription EktKeywordsEktShort_TitleEktRelated_eventsEktContentSubTypeEktDisabledTaxCategory   DownloadAsset.aspx?id=2715e@=] @_>]  GRelated ItemsT&lt;p&gt;Preparation for Life After Fellowship Robert F. Todd, III, MD, PhD University of Michigan Medical School  It is the Best of Times&  Never before in the history of medical science have the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of the human genome and the &lt;/p&gt;the opportunities for advancement in the fields of hematology and oncology been greater. Sequencing of thPowerPoint Document(MDocumentSummaryInformation8(